You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
Biopharma’s boldest VC firm gets into lobbying
Pharma showers John Thune with campaign cash
All told, Sen. John Thune raked in more than $35,000 from pharmaceutical companies in February.